Articles related to Hepatology

Analysis of 285,680 patients shows a 1.03-1.38% reduction in cumulative mortality with rosuvastatin compared to atorvastatin, alongside varying risks for cardiovascular events, liver outcomes, and diabetes.

A 2023 study found that participants who consumed fast food for 20% or more of their meals accumulated excessive fat in their livers, highlighting the potential impact of dietary choices on liver health.

An estimated 5% of U.S. adults have consumed at least one potentially hepatotoxic herbal supplement in the past month, raising concerns about liver health risks associated with unregulated botanical products.

Emerging data suggest that lactated Ringer’s is associated with improved health outcomes and may be superior to normal saline in acute pancreatitis management.

Liver injuries tied to botanical supplements are on the rise, with cases nearly tripling in a decade. Healthcare providers should be aware of this growing concern and its implications for patient care.

In patients with both cirrhosis and atrial fibrillation, apixaban initiation was associated with lower rates of major bleeding compared to rivaroxaban or warfarin, without compromising thromboembolic protection.